Correlation Between EUDA Health and NewAmsterdam Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both EUDA Health and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EUDA Health and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EUDA Health Holdings and NewAmsterdam Pharma, you can compare the effects of market volatilities on EUDA Health and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EUDA Health with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of EUDA Health and NewAmsterdam Pharma.

Diversification Opportunities for EUDA Health and NewAmsterdam Pharma

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between EUDA and NewAmsterdam is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding EUDA Health Holdings and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and EUDA Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EUDA Health Holdings are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of EUDA Health i.e., EUDA Health and NewAmsterdam Pharma go up and down completely randomly.

Pair Corralation between EUDA Health and NewAmsterdam Pharma

Given the investment horizon of 90 days EUDA Health Holdings is expected to generate 0.83 times more return on investment than NewAmsterdam Pharma. However, EUDA Health Holdings is 1.21 times less risky than NewAmsterdam Pharma. It trades about -0.04 of its potential returns per unit of risk. NewAmsterdam Pharma is currently generating about -0.05 per unit of risk. If you would invest  444.00  in EUDA Health Holdings on December 30, 2024 and sell it today you would lose (78.00) from holding EUDA Health Holdings or give up 17.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

EUDA Health Holdings  vs.  NewAmsterdam Pharma

 Performance 
       Timeline  
EUDA Health Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days EUDA Health Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
NewAmsterdam Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days NewAmsterdam Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

EUDA Health and NewAmsterdam Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with EUDA Health and NewAmsterdam Pharma

The main advantage of trading using opposite EUDA Health and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EUDA Health position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.
The idea behind EUDA Health Holdings and NewAmsterdam Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data